Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: resistance

November 22, 2023 Drug delivery / Pharma applications

Cyclodextrins: prospective nanocarriers for the delivery of antibacterial agents, against bacteria  that are resistant  to antibiotics

A review with 303 references Several different kinds of cyclodextrin nanocarriers (β-CD, HP-β-CD, Meth-β-CD, cationic CD, sugar-grafted CD) are utilized

Continue reading

February 3, 2022 Drug delivery / Pharma applications

Scientists are racing to develop more COVID antivirals

Nature News evaluated antiviral drugs developed for the treatment of Covid-19. Clinical-trial data showed that molnupiravir, developed by the pharmaceutical

Continue reading

November 8, 2018 Drug delivery / Pharma applications

Strategies against antifungal resistance

A recent paper in Drug Design, Development and Therapy gives an overview on the new strategies to combat antifungal drug

Continue reading

August 23, 2018 Drug delivery / Pharma applications

Nanocarriers for the delivery of antimicrobial agents to fight resistance mechanisms

The EU FP7 International Training Project (FP7-PEOPLE-ITN-2013-608407) arrived to the end (2014-2018). The worldwide spread of antibiotic-resistant microorganisms can be

Continue reading

Recent Posts

  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex – A Comparison of Analytical Techniques
  • Effect of cyclodextrins on cardiometabolic indices: a systematic review and meta-analysis of randomized controlled trials

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (427)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (230)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (411)
  • Other industrial use (111)
  • Pharma applications (1,205)
  • Supramolecular systems (44)
  • Uncategorized (163)

Top Posts

  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • 4th International Aquatic Biotechnology Symposium
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • Are cyclodextrins safe for intravitreal injections?
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex - A Comparison of Analytical Techniques
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Antibody conjugated cyclodextrin for tumor drug delivery
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Impact of Cholesterol Depletion by Methyl BCD on Dopamine Transmission Dynamics in Brain

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...